Sujitha Jayaprakash
YOU?
Author Swipe
View article: Unlocking therapeutic potential: Exploring nuclear receptors in brain cancer treatment
Unlocking therapeutic potential: Exploring nuclear receptors in brain cancer treatment Open
Brain cancer remains among the most lethal malignancies worldwide, with approximately 321,476 new cases and 248,305 deaths reported globally in 2022. The treatment of malignant brain tumors presents substantial clinical challenges, primari…
View article: The emerging role of human papillomavirus in lung cancer
The emerging role of human papillomavirus in lung cancer Open
Lung cancer stands as one of the most lethal diseases and is the foremost cause of cancer-related mortalities worldwide. The pathophysiology of lung cancer is multifaceted, and it includes multiple cell signaling pathways and other complex…
View article: Delineating the role of nuclear receptors in colorectal cancer, a focused review
Delineating the role of nuclear receptors in colorectal cancer, a focused review Open
View article: Unraveling the Potential Role of NEDD4-like E3 Ligases in Cancer
Unraveling the Potential Role of NEDD4-like E3 Ligases in Cancer Open
Cancer is a deadly disease worldwide, with an anticipated 19.3 million new cases and 10.0 million deaths occurring in 2020 according to GLOBOCAN 2020. It is well established that carcinogenesis and cancer development are strongly linked to…
View article: Demystifying the Functional Role of Nuclear Receptors in Esophageal Cancer
Demystifying the Functional Role of Nuclear Receptors in Esophageal Cancer Open
Esophageal cancer (EC), an aggressive and poorly understood disease, is one of the top causes of cancer-related fatalities. GLOBOCAN 2020 reports that there are 544,076 deaths and 604,100 new cases expected worldwide. Even though there are…